OR WAIT null SECS
June 17, 2022
Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.
SCHOTT is planning to triple its ready-to-use vial production capacity in the United States to meet increasing demand for storing injectable drugs.
Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.
Measure tackles infant formula, cosmetics, diagnostics plus drug development and access.
Humanigen and PCI Pharma Servicesare partnering up for the commercialization of lenzilumab.
MHRA has been accepted as a full member of three international work-sharing partnerships aimed at making sure medicines and medical devices are regulated safely and efficiently across the world.
NICE has published its final draft guidance recommending the use of Vazkepa (icosapent ethyl) in adults to reduce heart attacks and strokes.
Merck has entered into a collaboration with Agilent Technologies with the aim of filling the industry gap in PAT for downstream processing.
A new polymer surface material has been invented by researchers in Sweden that uses electrical signals to both capture and release biomolecules.
Exothera, LogicBioTherapeutics, and Polyplus-transfection, are collaborating on the development of a scalable AAV manufacturing platform.